BNGO Bionano Genomics Inc

USD 4.00 0.00 ( 0.00%)
Icon

Bionano Genomics Inc (BNGO) Financial Statements

COMMON STOCK | Medical Instruments & Supplies | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 4.00

0.00 (0.00%)

USD 0.01B

0.10M

USD 7.00(+75.00%)

USD 2.62 (-34.50%)

Icon

BNGO

Bionano Genomics Inc (USD)
COMMON STOCK | NSD
USD 4.00
0.00 ( 0.00%)

Bionano Genomics Inc (BNGO) Annual Income Statement (USD)

BNGO Quarterly Financials (USD)

Frequently Asked Questions About Bionano Genomics Inc (BNGO) Stock

Bionano Genomics Inc's (BNGO) last reported annual revenue was USD 30.78 Million.

Bionano Genomics Inc's (BNGO) annual revenue growth rate based on the revenue reported in the past 5 years is : 24.89%

Bionano Genomics Inc's(BNGO) is not profitable as of its last reported annual financials.

The net profit margin for Bionano Genomics Inc's(BNGO) from its laster reported year is -363.98%

The return on equity (ROE) for Bionano Genomics Inc's(BNGO) from its last reported annual financials is : -170.33%

The return on assets (ROA) for Bionano Genomics Inc's(BNGO) from its last reported annual financials is : -32.76%

The return on invested capital (ROIC) for Bionano Genomics Inc's(BNGO) from its last reported annual financials is : -103.33%

The Debt to Equity ratio for Bionano Genomics Inc's(BNGO) from its last reported annual financials is : 0.00%

The dividend yield for Bionano Genomics Inc's(BNGO) from its laster reported year is 0.00%

Bionano Genomics Inc's(BNGO) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...